Authors: Selmer, Randi, Haglund, Bengt, Furu, Kari, Andersen, Morten, Nørgaard, Mette, Zoëga, Helga, Kieler, Helle
Source:
Selmer, R, Haglund, B, Furu, K, Andersen, M, Nørgaard, M, Zoëga, H & Kieler, H 2016, ' Individual-based versus aggregate meta-analysis in multi-database studies of pregnancy outcomes : the Nordic example of selective serotonin reuptake inhibitors and venlafaxine in pregnancy ', Pharmacoepidemiology and Drug Safety, vol. 25, no. 10, pp. 1160-1169 . https://doi.org/10.1002/pds.4033
Selmer, R, Haglund, B, Furu, K, Andersen, M, Nørgaard, M, Zoëga, H & Kieler, H 2016, ' Individual-based versus aggregate meta-analysis in multi-database studies of pregnancy outcomes : the Nordic example of selective serotonin reuptake inhibitors and venlafaxine in pregnancy ', Pharmacoepidemiology and Drug Safety . https://doi.org/10.1002/pds.4033
Subject Terms: Adult, Cohort Studies, Databases, Factual, Female, Heart Defects, Congenital/chemically induced, Humans, Middle Aged, Pregnancy, Pregnancy Outcome, Registries, Research Design, Risk Factors, Scandinavian and Nordic Countries/epidemiology, Serotonin Uptake Inhibitors/administration & dosage, Serotonin and Noradrenaline Reuptake Inhibitors/administration & dosage, Venlafaxine Hydrochloride/administration & dosage, Ventricular Outflow Obstruction/chemically induced, Young Adult
Access URL:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::670acb6ca215528419aa9df451e5476b
https://portal.findresearcher.sdu.dk/da/publications/6c83782e-61e6-4a08-921c-2785278e9534
Source: Targeted oncology, 4 (2
Index Terms: Sciences bio-médicales et agricoles, Adjuvants, Immunologic -- administration & dosage, Anthracyclines -- administration & dosage, Antibodies, Monoclonal -- administration & dosage, Antibodies, Monoclonal -- adverse effects, Breast Neoplasms -- immunology, Breast Neoplasms -- mortality, Breast Neoplasms -- pathology, Breast Neoplasms -- physiopathology, Breast Neoplasms -- therapy, Drug Resistance, Neoplasm, Female, Heart Failure -- chemically induced, Humans, Oxidative Stress, Protein Kinase Inhibitors -- administration & dosage, Protein Kinase Inhibitors -- adverse effects, Quinazolines -- administration & dosage, Quinazolines -- adverse effects, Receptor, Epidermal Growth Factor -- antagonists & inhibitors, Receptor, erbB-2 -- antagonists & inhibitors, Receptor, erbB-2 -- immunology, Survival Rate, Ventricular Outflow Obstruction -- chemically induced, Anti-HER-2 therapies, Breast cancer, Cardiotoxicity, Lapatinib, Trastuzumab, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Targeted oncology, 4 (2
Index Terms: Sciences bio-médicales et agricoles, Adjuvants, Immunologic -- administration & dosage, Anthracyclines -- administration & dosage, Antibodies, Monoclonal -- administration & dosage, Antibodies, Monoclonal -- adverse effects, Breast Neoplasms -- immunology, Breast Neoplasms -- mortality, Breast Neoplasms -- pathology, Breast Neoplasms -- physiopathology, Breast Neoplasms -- therapy, Drug Resistance, Neoplasm, Female, Heart Failure -- chemically induced, Humans, Oxidative Stress, Protein Kinase Inhibitors -- administration & dosage, Protein Kinase Inhibitors -- adverse effects, Quinazolines -- administration & dosage, Quinazolines -- adverse effects, Receptor, Epidermal Growth Factor -- antagonists & inhibitors, Receptor, erbB-2 -- antagonists & inhibitors, Receptor, erbB-2 -- immunology, Survival Rate, Ventricular Outflow Obstruction -- chemically induced, Anti-HER-2 therapies, Breast cancer, Cardiotoxicity, Lapatinib, Trastuzumab, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL: